Mycosis Fungoides
📧 Sign up to get email alerts when something new happens for Mycosis Fungoides.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma [Phase 2]
Phase II trial update for intratumoral IL12 plasmid electroporation in cutaneous T cell lymphomas, including mycosis fungoides; study termin…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides [Phase 1, Phase 2]
A Phase 1/2 trial comparing low-dose total skin electron beam therapy with vorinostat versus TSEBT alone in mycosis fungoides was terminated…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level [Phase 2]
Phase 2 trial results of brentuximab vedotin (SGN-35) in patients with mycosis fungoides/cutaneous T-cell lymphoma with variable CD30 expres…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001) [Phase 2]
A Phase 2 clinical trial evaluating oral vorinostat (SAHA) for advanced cutaneous T-cell lymphoma, including Sézary syndrome and mycosis fun…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides
A Phase 2 study evaluating total skin electron beam therapy (12 Gy) for stage IB-IIIA mycosis fungoides has been terminated, with results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) [Phase 2]
Phase 2 trial of A-dmDT390-bisFv(UCHT1) immunotoxin for cutaneous T-cell lymphoma (CTCL) has completed, with results from the study summariz…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma [Phase 2]
Phase 2 study update of the HDAC inhibitor quisinostat in previously treated Cutaneous T-Cell Lymphoma (Stage Ib-IVa) has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides [Phase 2]
Phase 2 clinical trial evaluating the safety and effectiveness of the A-dmDT390-bisFv(UCHT1) fusion protein in patients with mycosis fungoid…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
This clinical trial update reports termination of the study NCT01556828, which analyzed cutaneous and hematologic disorders using high-throu…
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Early Diagnosis of Mycosis Fungoides [NA]
The document provides an update on a clinical trial investigating early diagnosis of mycosis fungoides, a form of cutaneous T-cell lymphoma,…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL [Phase 2]
A Phase 2 trial investigating a combination of bexarotene and rosiglitazone for cutaneous T-cell lymphoma has been completed, with results p…
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides [Phase 2]
Phase 2 trial results for Total Skin Electron Beam Therapy in stage IB-IIIA mycosis fungoides were posted.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Effect of Denileukin Diftitox on Immune System in CTCL Patients
This completed trial update reports on the effects of denileukin diftitox on the immune system in patients with cutaneous T-cell lymphoma, i…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial assessed the combination of O6-Benzylguanine with topical Carmustine in patients with early-stage cutaneous T-cell lymphom…
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas [Phase 1, Phase 2]
A Phase 1/2 study evaluating CPG 7909 with local radiotherapy for recurrent low-grade lymphomas has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides [Phase 2]
This entry provides an update on a Phase 2 trial of combination chemotherapy for advanced or recurrent mycosis fungoides. Mycosis fungoides …
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas [Phase 1]
This Phase 1 trial evaluated entinostat (MS-275) plus isotretinoin in adults with metastatic or advanced solid tumors or various lymphomas; …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: 506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma [Phase 2]
A Phase 2 trial evaluating 506U78 for recurrent or refractory cutaneous T-cell lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: 506U78 in Treating Patients With Lymphoma [Phase 2]
Phase 2 clinical trial update on the agent 506U78 for various lymphomas; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides [Phase 1, Phase 2]
Phase 1/2 trial evaluating interleukin-12 and interleukin-2 in patients with mycosis fungoides and Sezary syndrome. The study was terminated…
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Interleukin-2 in Treating Patients With Mycosis Fungoides [Phase 1]
Phase 1 trial evaluating interleukin-2 in patients with mycosis fungoides; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides [Phase 2]
Phase 2 trial evaluating the safety and efficacy of Nitrogen Mustard (mechlorethamine) for treating Mycosis fungoides has completed with res…
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides [Phase 2]
An open-label Phase 2 study evaluating the safety and efficacy of a 0.04% topical mechlorethamine formulation in Mycosis fungoides has compl…
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome [Phase 3]
A Phase 3 trial evaluating an unspecified human monoclonal antibody for mycosis fungoides and Sézary syndrome has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides [Phase 1]
A multicentre Phase I trial from the University of Cologne evaluates engineered CD30-targeted T cells for relapsed or refractory primary cut…